Acadia Pharmaceuticals (ACAD) PT Raised to $61 at Piper Jaffray
Tweet Send to a Friend
Piper Jaffray raised its price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $61.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
